Viewing Study NCT01381861


Ignite Creation Date: 2025-12-24 @ 12:43 PM
Ignite Modification Date: 2026-05-31 @ 6:43 AM
Study NCT ID: NCT01381861
Status: COMPLETED
Last Update Posted: 2019-03-05
First Post: 2011-06-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
Sponsor: Tracon Pharmaceuticals Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Ovarian Cancer View
None Fallopian Tube Carcinoma View
None Primary Peritoneal Carcinoma View
Keywords: